32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
- 1 August 1997
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: